LJI scientists identify an autoimmune response that may help explain why Parkinson’s disease is twice as prevalent in men. Scientists at the La Jolla Institute for Immunology (LJI) have identified a potential new target for Parkinson’s disease treatment. Their research highlights the role of a specific brain cell protein in triggering the disease and may [...]from SciTechDaily https://ift.tt/FIPBtOc
